Further Mechanisms and Locations in Which Antisporozoite Antibodies Neutralize Malaria Sporozoites.

LETTER

Having worked in this area for many years, I read with much interest the recent article “Antibody-Mediated Protection against Plasmodium Sporozoites Begins at the Dermal Inoculation Site” by Flores-Garcia et al. (1). It is now universally recognized, as described by the authors, that mosquitoes inject most of their sporozoites into extravascular skin tissue rather than directly into blood vessels (2, 3). From there, they migrate through the dermis to enter blood vessels (3) and are carried to the liver, where they invade hepatocytes to continue their development. The authors further note that sporozoites spend much of their extracellular time at the skin inoculation site, thus rendering them vulnerable to antibody-mediated destruction at this site. Such antibody-mediated immobilization or destruction of sporozoites has been shown both in vitro and in vivo (3–5). I am gratified that the authors have corroborated these prior findings made by us and several other authors and have expanded them with new data.

The authors concluded that antibodies targeting the migratory sporozoites exert a large proportion of their protective effect at the inoculation site but that the mechanisms by and location in which they neutralize parasites have not been fully elucidated (1). I would like, however, to call attention to the evidence we presented in our 2009 publication (5) in which we elucidated an entirely new and complementary way in which sporozoites can be neutralized by host antibodies.

It is known that living sporozoites release large quantities of soluble circumsporozoite protein (CSP) into their environment both in vitro and in vivo and that soluble CSP is found within the saliva of malaria-infected mosquitoes (6, 7). Thus, infected mosquitoes introduce into the skin of immunized hosts not only CSP-covered sporozoites but also soluble CSP, both of which encounter and interact with homologous anti-CSP antibodies in situ within avascular tissue of the host dermis. We presented evidence that many of the sporozoites are trapped there within apparent immune complexes, as determined by confocal microscopy and specific staining with fluorescein isothiocyanate (FITC)-conjugated protein A and A/C. Thus, sporozoites were not only immobilized by CS antibodies as has previously been shown but were additionally entrapped by being encased within these immune complexes. I respectfully suggest, in disagreement with the conclusions of the authors (1), that the mechanisms by and location in which antisporozoite antibodies neutralize parasites have indeed been further elucidated, as demonstrated in our 2009 paper (5).